News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Oliver Van Oekelen: An overview on Sequencing Immunotherapy for Multiple Myeloma
Photo from doximity.com
Jun 20, 2024, 14:09

Oliver Van Oekelen: An overview on Sequencing Immunotherapy for Multiple Myeloma

Oliver Van Oekelen, at Mount Sinai Beth Israel, posted on X:

“Immunotherapy has become a cornerstone of myeloma treatment! Next years will teach how to optimally implement the treatment options that give hope to mmsm patients. Honored to work with Meera Mohan and Adam D Cohen to provide an overview of current data.”

Oliver Van Oekelen: An overview on Sequencing Immunotherapy for Multiple Myeloma

View the article attached to the post.
Source: Oliver Van Oekelen/X

Adam D Cohen cancer Meera Mohan Mount Sinai Beth Israel myeloma treatment Oliver Van Oekelen OncoDaily Oncology
Special Coverage
Blog
Dec 30, 2024, 19:52
CelloType: A New Machine Learning Tool for Analyzing Cancer Cells and Tissues
Blog
Dec 30, 2024, 19:26
“QI Scholar Nursing Presentations Part 2” from the SIOP Nursing Network
Science
Dec 30, 2024, 13:52
Nico Gagelmann: Selected clinical studies 2024 in hematology
Insight
Dec 30, 2024, 13:43
Roupen Odabashian: When it comes to real-life cases, physicians still outperform AI
Blog
Dec 30, 2024, 13:42
Shaban Juma: The key to being one step ahead in the fight against cancer
Positive
Dec 30, 2024, 13:42
Improving the lives of children with cancer everywhere - St. Jude Children's Research Hospital
Blog
Dec 30, 2024, 13:37
Matthew Pech: The failure of ex vivo gene therapy for sickle cell and the role of the TPP in the drug development process
Insight
Dec 30, 2024, 13:35
James Crowley: Elevated expression of CCR7 is generally indicative of poor prognosis in cancers
Insight
Dec 30, 2024, 13:30
Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer
Blog
Dec 30, 2024, 13:25
Sanjay Popat: Wouldn’t it be great if FDA Oncology approvals were mutually approvable by MHRA?
Insight
Dec 30, 2024, 13:23
Satya Prakash Yadav: 2024 blockbuster Menin inhibitor for infant ALL
Insight
Dec 30, 2024, 13:10
Promising response to lurbinectedin in NUT carcinoma by M.V. Sánchez Becerra et al. - Vivek Subbiah